NG
LLY icon

Novem Group’s Eli Lilly LLY Stock Holding History

Novem Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$92K Sell
100
-100
-50% -$101K 0.01% 426
2025
Q4 		$215K Buy
200
+100
+100% +$95.6K 0.02% 392
2025
Q3 		$76.3K Hold
100
– – 0.01% 411
2025
Q2 		$78K Hold
100
– – 0.01% 398
2025
Q1 		$82.6K Sell
100
-100
-50% -$83.2K 0.01% 359
2024
Q4 		$154K Buy
+200
New +$166K 0.02% 357

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Novem Group's LLY Position: Q1 2026 in Review

Novem Group increased its Eli Lilly (LLY) stake by 13% in Q1 2026, buying an estimated $199K and bringing the position to 1,713 shares worth $1.58M. The position accounts for 0.18% of the portfolio, ranked #101.

Novem Group first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.96M in Q2 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Novem Group held 1,713 shares of Eli Lilly worth $1.58M as of Q1 2026.
  • Novem Group bought 196 Eli Lilly shares in Q1 2026, an estimated $199K.
  • Eli Lilly made up 0.18% of Novem Group's portfolio in Q1 2026, its #101 holding.
  • Novem Group first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Novem Group's Eli Lilly position peaked at $1.96M in Q2 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Novem Group's 13F filing for Q1 2026, filed 13 Apr 2026.